Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?

Por Al-Kassmy, Jawad, Pedersen, Jannie, Kobinger, Gary
Publicado no Viruses (2020)

Inflammatory pathways of importance for management of inflammatory bowel disease

Por Pedersen, Jannie, Coskun, Mehmet, Soendergaard, Christoffer, Salem, Mohammad, Nielsen, Ole Haagen
Publicado em 2014

Cell Culture Studies of the Efficacy and Barrier to Resistance of Sofosbuvir-Velpatasvir and Glecaprevir-Pibrentasvir against Hepatitis C Virus Genotypes 2a, 2b, and 2c

Por Ramirez, Santseharay, Fernandez-Antunez, Carlota, Mikkelsen, Lotte S., Pedersen, Jannie, Li, Yi-Ping, Bukh, Jens
Publicado no Antimicrob Agents Chemother (2020)

Neutralizing Antibodies in Patients with Chronic Hepatitis C, Genotype 1, against a Panel of Genotype 1 Culture Viruses: Lack of Correlation to Treatment Outcome

Por Pedersen, Jannie, Jensen, Tanja B., Carlsen, Thomas H. R., Schønning, Kristian, Christensen, Peer Brehm, Laursen, Alex Lund, Krarup, Henrik, Bukh, Jens, Weis, Nina
Publicado em 2013

Breadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3a

Por Carlsen, Thomas H.R., Pedersen, Jannie, Prentoe, Jannick C., Giang, Erick, Keck, Zhen-Yong, Mikkelsen, Lotte S., Law, Mansun, Foung, Steven K. H., Bukh, Jens
Publicado no Hepatology (2014)

Neutralization resistance of hepatitis C virus can be overcome by recombinant human monoclonal antibodies

Por Pedersen, Jannie, Carlsen, Thomas H. R., Prentoe, Jannick, Ramirez, Santseharay, Jensen, Tanja B., Forns, Xavier, Alter, Harvey, Foung, Steven K. H., Law, Mansun, Gottwein, Judith, Weis, Nina, Bukh, Jens
Publicado no Hepatology (2013)